Feb 23, 2021
COVID-19 vaccine shipments to states increasing by another million doses
This news has been received from: New York Post
All trademarks, copyrights, videos, photos and logos are owned by respective news sources. News stories, videos and live streams are from trusted sources.
More On: COVID vaccine MTA will vaccinate one thousand transit workers per week in Brooklyn Ikea stores in Israel offer COVID-19 vaccinations NYC charter schools deserve COVID-19 justice NYC plans for at-home shots of Johnson & Johnson COVID vaccine
The Biden administration said Tuesday that it’s upping the total number of COVID-19 vaccine doses sent to states each week — from 13.5 million doses to 14.5 million.
The White House’s COVID-19 task force made the announcement on Twitter.
The increased vaccine supply comes a week after the White House announced it was boosting the number of weekly doses being shipped out from 11 million to 13.5 million.
So far, the US has distributed more than 82 million doses of the Pfizer and Moderna vaccines, the Centers for Disease Control and Prevention said.
But the vaccine rollout was plagued by shipping problems last week as winter storms across the US created delays.A FedEx driver carries a box to Colorado Gov. Jared Polis so he can sign for delivery of the state’s first shipment of COVID-19 vaccine on Dec. 14, 2020 in Denver.AP Photo/David Zalubowski
Officials have said that vaccine shipments should be back on track by the middle of the week.
“It’s unfortunate that it was a setback, but it’s a temporary setback, and when you just, you know, put your foot to the accelerator and really push, we’ll get it up to where we need to be by the middle of the week,” Dr. Anthony Fauci told “Meet the Press” on Sunday.Filed under Coronavirus , COVID vaccine , joe biden , white house , 2/23/21
News Source: New York Post
Italy blocks the export of AstraZeneca vaccines to Australia, produced in the EU
> File: the race for vaccines
Italy has blocked the export to Australia of doses of AstraZeneca’s anti-Covid vaccine produced on European soil, the first application of a control mechanism put in place by Brussels, the Italian government announced Thursday.
This is the first time that a member state has blocked an export via this mechanism, a European source told ..
Rome communicated its decision on February 26 to the European Commission, which raised no objections. The Foreign Ministry said in a statement that this export refusal related to 250,700 doses from the Swedish-British laboratory.
Italy justified this by “the persistent shortage of vaccines and the delays in supply from AstraZeneca” in the EU and Italy, the “large quantity” of doses concerned and the fact that Australia is considered a “non-vulnerable” country by the EU mechanism.
AstraZeneca has been heavily criticized by European governments after announcing in January that it could deliver only a third of the 120 million doses it had initially promised to the 27 EU member states in the first quarter, due to manufacturing difficulties in the first quarter. a Belgian factory.
The argument did not convince Brussels, which recalled that three other factories were mentioned in the contract signed with the EU.
The Australian Foreign Office on Friday played down the impact of Italy’s decision on its vaccination plan.Dose control
The delivery of doses of AstraZeneca that the Italian government has blocked “was not included in our distribution plan for the next few weeks,” a spokesman for the ministry told .. “It’s just one shipment from one country,” he said.
Australia, which approved the AstraZeneca vaccine in mid-February, has already received a delivery of 300,000 doses of this vaccine, and the first are to be injected Friday to health workers in the south of the country.
These 300,000 doses, coming in addition to doses of the Pfizer vaccine, should make it possible to hold out until the pace of Australian production of AstraZeneca is increased. About 50 million doses need to be produced locally.
Although denying itself to specifically target AstraZeneca, the European Commission has been imposing safeguards on exports of anti-Covid vaccines produced in the EU since the end of January, in order to keep control of the doses intended for the Twenty-Seven.A first
The system provides that the States themselves exercise this control via their national customs: each State examines export authorization applications for vaccines manufactured on its territory, before seeking the opinion of the Commission, to which it must comply. conform.
The Commission “keeps up to date a table of the export requests for anti-Covid vaccines and the corresponding commitments” of the laboratories under the pre-order agreements made by the EU, and it is on this basis that it has approved the Italian decision, according to another European source.
AstraZeneca, which manufactures its anti-Covid vaccine at sites in Belgium and the Netherlands, has a bottling and packaging plant in Italy in Anagni, near Rome.
As in many Member States, voices were raised in Italy to criticize the slowness of the vaccination campaign, launched with fanfare at the end of December but which quickly encountered delays in deliveries.
At this stage, 1.51 million Italians have been vaccinated, mainly health workers and the elderly, and 4.84 million doses have been administered, for a total population of some 60 million.
Read also: COVID-19 in 24 hours: slowness on AstraZeneca, Dunkirk, young people …
Follow La Tribune
Let’s share economic information, receive our newsletters